Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous GLP-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine
Clinical Review & Scope This guide is intended for educational purposes and reflects current evidence as of 2026
In people without deficiencies, change may be slight or non-existent, and it is reasonable to interpret these accounts with caution
In this review article, we focus on necroptosis and autophagy pathways, giving a comprehensive understanding of their molecular mechanisms, roles in CP-induced AKI, and the potential of targeting necroptosis or autophagy pathways for attenuation of CP-induced AKI
Same-day processing before 2:00 PM CST
The Pharmaceutical Benefits Scheme: Somatostatin 2025 [Available from: Van Been A, Laville M, Tack J